Breast Cancer Detection Not Raised with Adjunct Ultrasonography
|
By MedImaging International staff writers Posted on 08 Apr 2019 |
A new study suggests that the benefit of adding breast ultrasonography as a supplement to screening mammography for women with dense breasts may not outweigh associated harms.
Researchers at the University of Washington (UW; Seattle, USA), the University of California Davis (UCD; USA), and the American Cancer Society conducted an observational study of two breast cancer surveillance registries from March 2014 to December 2018, with 6,081 screening mammography plus same-day ultrasonography examinations matched to 30,062 screening mammograms without screening ultrasonography in order to compare both breast cancer screening procedures.
The results revealed that women with dense breasts, women who were younger than 50 years, and women with a family history of breast cancer were more likely to receive screening mammography with ultrasonography examinations than screening mammography alone. Cancer detection rate and interval cancer rates were similar among groups, but there were significantly higher rates of false-positive biopsy and short-interval follow-up in the mammography plus ultrasonography group, and a significantly lower predictive value for biopsy recommendation. The study was published on March 18, 2019, in JAMA Internal Medicine.
“Our observational cohort study of ultrasonography screening in women across a range of breast cancer risk found modest, nonsignificant benefits and rates of screening harms that were high and consistent with prior reports,” concluded lead author Janie Lee, MD, MSc, of UW, and colleagues. “To apply supplemental ultrasonography screening with greater effectiveness, we suggest that additional efforts are needed to more accurately identify women who will benefit from supplemental screening.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Washington
University of California Davis
Researchers at the University of Washington (UW; Seattle, USA), the University of California Davis (UCD; USA), and the American Cancer Society conducted an observational study of two breast cancer surveillance registries from March 2014 to December 2018, with 6,081 screening mammography plus same-day ultrasonography examinations matched to 30,062 screening mammograms without screening ultrasonography in order to compare both breast cancer screening procedures.
The results revealed that women with dense breasts, women who were younger than 50 years, and women with a family history of breast cancer were more likely to receive screening mammography with ultrasonography examinations than screening mammography alone. Cancer detection rate and interval cancer rates were similar among groups, but there were significantly higher rates of false-positive biopsy and short-interval follow-up in the mammography plus ultrasonography group, and a significantly lower predictive value for biopsy recommendation. The study was published on March 18, 2019, in JAMA Internal Medicine.
“Our observational cohort study of ultrasonography screening in women across a range of breast cancer risk found modest, nonsignificant benefits and rates of screening harms that were high and consistent with prior reports,” concluded lead author Janie Lee, MD, MSc, of UW, and colleagues. “To apply supplemental ultrasonography screening with greater effectiveness, we suggest that additional efforts are needed to more accurately identify women who will benefit from supplemental screening.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Washington
University of California Davis
Latest Ultrasound News
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
Deep Learning Model Predicts Alzheimer’s Disease Outcomes from Baseline MRI
Alzheimer’s disease, which accounts for 60% to 70% of dementia cases worldwide, remains difficult to predict early in its course. Accurate prognostication typically relies on neuropsychological testing,... Read more
AI Body Composition MRI Analysis Predicts Cardiometabolic Disease Risk
Cardiometabolic disease, driven by interactions between cardiovascular and metabolic systems, is a leading cause of morbidity and mortality. Risk assessment often relies on body mass index, which overlooks... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more
New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
Mevion Medical Systems (Littleton, MA, USA) has introduced the MEVION S250-FIT Proton Therapy System to the European radiation oncology community at ESTRO 2026, the first proton therapy platform designed... Read more
3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
Ensuring consistent immobilization and soft-tissue positioning is central to safe, effective head and neck radiotherapy, where protection of organs at risk must be balanced with dose accuracy.... Read more
Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
Diagnosing endometriosis remains challenging, particularly for superficial peritoneal endometriosis, the most common subtype, which is often missed on conventional imaging and typically requires laparoscopic... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







